NEW YORK, Dec. 18, 2014 /PRNewswire/ -- This BCC Research report estimates the global diagnostics market for autoimmune diseases, with CAGR projections for the period 2014 to 2019. Market size estimates for pre-treatment and during-treatment phases are also presented. Estimates for ex-vivo diagnostics techniques such as X-ray and other imaging-based techniques are also covered in this report.
Use this report to:
- Identify the structure of the global diagnostics market for autoimmune diseases and learn about the major challenges and opportunities it faces.
- Learn about the current industry structure and future trends.
- Review and analyze the patents awarded and assess technological trends.
- Learn about the government regulations in various countries with regard to the in vitro diagnostic industry of which the autoimmune disease diagnostics form a subset.
Highlights
- The global market value for autoimmune disease diagnostics for 2013 was valued at $11.9 billion. This is expected to reach about $12.1 billion in 2014 and $13.1 billion in 2019, with a compound annual growth rate (CAGR) of 1.6% for the five-year period, 2014 to 2019.
- The size of the global pre-treatment market is estimated to be $226.8 million in 2014 and $236.5 million by 2019, growing at a CAGR of 0.8% for the five-year period, 2014 to 2019.
- The during-treatment market is estimated to reach about $11.9 billion in 2014 and nearly $12.9 billion by 2019, growing at a CAGR of 1.7% for the five-year period, 2014 to 2019.
INTRODUCTION
STUDY GOALS AND OBJECTIVES
Autoimmune diseases arise when the immune system attacks the body's organs, tissues and cells. There are at least 70 clinically distinct autoimmune diseases, including insulin dependent diabetes mellitus (type 1 diabetes), multiple sclerosis, systemic lupus erythematosus (SLE), rheumatoid arthritis, inflammatory bowel disease, psoriasis, uveitis and autoimmune thyroid disease. Autoimmune diseases collectively affect approximately 5% to 10% of the population of the developed world. Autoimmune
diseases disproportionately affect women at a rate of two to nine times greater than for men. This report investigates the autoimmune disease diagnostics market with supporting tables and figures to illustrate projections.
The goals of this report are to:
- Provide an overview of the autoimmune disease diagnostics industry.
- Explain the current industry structure and future trends.
- Analyze the industry for new developments and trends.
- Review and analyze the patents awarded and assess technological trends.
- Provide an estimate of global market size by disease.
SCOPE OF REPORT
The report provides a thorough background of the structure of the market and outlines the chief challenges and opportunities it faces. This report estimates the global
diagnostics market for autoimmune diseases. Market size for the years 2012, 2013, 2014 and 2019 is presented. In addition, market size by various segments, namely
geographic regions, gender and disease phase (pre-treatment and in-treatment) is included. Market size estimates for pre-treatment and during-treatment phases are presented. The pre-treatment and during-treatment analyses consider the complete spectrum of tests available, including autoimmune-specific tests and complementary tests such as routine blood analyses. The estimates also include ex-vivo diagnostics techniques such as X-ray and other imaging-based techniques.
Certain autoimmune disorders are more prevalent than others and form the bulk of the diseases. This report covers the market specifically for these more prevalent disorders, namely:
- Rheumatoid arthritis.
- Inflammatory bowel disease.
- Type 1 diabetes.
- Multiple sclerosis.
- Systemic lupus erythematous (SLE).
INTENDED AUDIENCE
This report is a valuable tool for anyone assessing the autoimmune disease diagnostics market and attempting to devise a strategy to successfully compete in this market.
The report is expected to be invaluable for business planners, acquisition specialists, licensing strategists, product managers, market research analysts, investment consultants and others interested in the autoimmune disease diagnostics market and its products, participants and future.
Read the full report: http://www.reportlinker.com/p02374322-summary/view-report.html
About Reportlinker
ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - instantly, in one place.
http://www.reportlinker.com
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/autoimmune-disease-diagnostics-global-markets-300011952.html
SOURCE Reportlinker
Share this article